Showing results (351-360 of 461) with videos related to
Sort By:
Pageof 47
Current Clinical Pharmacology|January 18, 2011
Pharmacodynamic biomarkers in model-based drug development in oncologyRon J Keizer, Jan H M Schellens, Jos H Beijnen, et al.Current Clinical Pharmacology|January 18, 2011
A comprehensive literature search: drugs as possible triggers of Takotsubo cardiomyopathyPedro AmarilesCurrent Clinical Pharmacology|April 7, 2016
Drugs as Possible Triggers of Takotsubo Cardiomyopathy: A Comprehensive Literature Search - Update 2015Pedro Amariles, Laura CifuentesCurrent Clinical Pharmacology|November 14, 2013
Bupropion-SR for smoking reduction and cessation in alcohol-dependent outpatients: a naturalistic, open-label studyMaher Karam-Hage, Jason D Robinson, Ashutosh Lodhi, et al.Current Clinical Pharmacology|November 14, 2013
Clinical relevance of the interaction when switching non-nucleoside reverse transcriptase inhibitors in patients infected with HIVEric Dailly, Clotilde Allavena, Guillaume Deslandes, et al.Current Clinical Pharmacology|November 14, 2013
Pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitorReinhold KreutzCurrent Clinical Pharmacology|November 14, 2013
Cardiotonic steroids in adaptation to dietary salt intakeLarry Dial, Jiang Liu, Joseph I ShapiroCurrent Clinical Pharmacology|March 22, 2012
Adherence to Antiretroviral Therapy Among Iranian HIV/AIDS PatientsHossein Khalili, Roxane Rohani, Seyedahmad Seyedalinaghi, et al.Current Clinical Pharmacology|March 22, 2012
Pharmacogenetics and anesthetic drugsVidya Chidambaran, Pornswan Ngamprasertwong, Alexander A Vinks, et al.Current Clinical Pharmacology|May 4, 2016
Resistance to Crizotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) with ALK Rearrangement: Mechanisms, Treatment Strategies and New Targeted TherapiesFrancesca Casaluce, Assunta Sgambato, Paola Claudia Sacco, et al.Pageof 47